Additionally, this patient exhibits amplification of EGFR, MET, and FGFR-1, with MET copy number reaching 32.76, which may alter the TME through activation of multiple signaling pathways, enhancing tumor cell invasiveness and metastatic potential, likely serving as the primary cause of HPD in this case. Here, FGFR1 is linked to neoplasm.